How the Treatment of Lung Cancer Has Been Transformed in the Era of Molecular Biomarker Testing

David L. Rimm, MD, PhD; Roy Herbst, MD, PhD

Drs Roy Herbst and David Rimm review how biomarker testing has transformed the way patients with lung cancer are treated, and how both medical oncologists and pathologists contribute to these changes.

Related Videos

September 7, 2018

Who Should Consider Genetic Testing?

Dr Andrey Antov identifies situations in which people may want to consider genetic testing.

January 30, 2014

Personalized Medicine and the Impact on the Pharmaceutical Company

Dr Agarwala hypothesizes how the future of the traditional pharmaceutical company may change with the developments in personalized medicine.